Northern Biomedical Research (NBR) specializes in non-clinical research with a focus on various therapeutic areas, including neurology, ophthalmology, cardiology, and orthopedics. With over 20 years of experience, NBR is recognized for its expertise in surgical implants and central nervous system (CNS) drug delivery. The company offers advanced interventional and imaging capabilities for evaluating cardiovascular therapeutics and devices, as well as models for assessing fracture healing, bone remodeling, and spinal fusion in orthopedics. Their targeted-delivery studies are designed for safety assessments, ensuring that the research meets industry standards.

NBR's capabilities extend to a wide range of therapeutic products, including gene therapies, oligonucleotides, small molecules, monoclonal antibodies, and medical devices. The organization is compliant with various regulatory standards, including FDA Good Laboratory Practice (GLP) and is accredited by AAALAC. Their facility is equipped with over 60,000 square feet of space, featuring multiple animal rooms and surgical suites, allowing for comprehensive research across various species, including non-human primates, canines, rodents, and swine. NBR's experienced team collaborates closely with clients to design effective targeted-delivery surgical studies, ensuring high-quality and cost-effective outcomes.

United States

Northern Biomedical Research is a non-clinical research organization focused on targeted delivery of therapeutics using advanced techniques. Our team is experienced in providing industry-leading research for targeted-delivery of drugs, biologics, gene/cell therapies, and medical devices.Â With a strong regulatory history and scientific background in neuroscience, cardiovascular research, ophthalmology, and orthopedics, our team works closely with Sponsors to design a non-clinical program to exedite the regulatory process.Â For more information, stop by Booth 250.Â Â

Northern Biomedical Research

Company Details